Dr. Henry Tse

Henry Tse is CTO and co-founder of Cytovale. He is leading the group to commercialize the application of deformability cytometry technology in early sepsis diagnosis using novel mechanical biomarkers. He graduated from the University of California, San Diego with an undergraduate degree in bioengineering prior to joining Professor Dino Di Carlo at the University of California, Los Angeles to earn his Ph.D. in biomedical engineering. In the Di Carlo lab, he focused on advancing the field of inertial microfluidics, and subsequently, the translation of these tools for applications in biology, medicine, and industry. Consequently, Henry is an inventor of the deformability cytometry technique and has authored publications highlighting the technology’s potential in a host of diagnostic applications. At Cytovale, his responsibilities include product development, data science, computer vision, and clinical studies.

Dr. Viktor Shkolnikov

At HP labs, Viktor Shkolnikov leads a team of scientists and engineers to develop novel fluidic and electrokinetic technologies for solving valuable medical diagnostics problems, such as minimally invasive diagnosis of cancer. His interests and expertise lie at the interface between medicine and fluid mechanics (and the associated physics, chemistry, and engineering) and he constantly seeks ways of how these can be leveraged to alleviate pain and improve health. Shkolnikov is also the author of “Principles of Microfluidics,” a fundamental text in the field. Shkolnikov received his BS, MS, and PhD degrees all in Mechanical Engineering and all from Stanford University.